
Company Website:
http://www.ubs.com
NEW YORK -- (Business Wire)
UBS AG announced today that it will redeem all of the outstanding
securities in each of the series set forth in the following table
(collectively, the “Affected Securities”):
| Securities |
|
| CUSIP |
|
ETRACS DJ-UBS Commodity Index 2-4-6 Blended Futures ETN due April
30, 2042
|
|
|
90267L201
|
|
ETRACS Monthly 2x Leveraged ISE Cloud Computing TR Index ETN due
October 4, 2041
|
|
|
90267E330
|
|
Exchange Traded Access Securities (E-TRACS) Short Platinum — Linked
to the Inverse Performance of the UBS Bloomberg CMCI Platinum Excess
Return due 2018
|
|
|
902641729
|
|
ETRACS Next Generation Internet ETN due July 19, 2041
|
|
|
90268A774
|
|
ETRACS Monthly 2x Leveraged Next Generation Internet ETN due July
19, 2041
|
|
|
90268A659
|
|
ETRACS ISE Solid State Drive Index ETN due September 13, 2041
|
|
|
90268A758
|
|
ETRACS Monthly 2x Leveraged ISE Solid State Drive Index ETN due
September 13, 2041
|
|
|
90268A741
|
Terms used but not defined herein shall have the meanings ascribed to
such terms in the Affected Securities.
The Call Settlement Date for the Affected Securities shall be June 6,
2013.
With respect to each series of Affected Securities, the amount payable
on the Call Settlement Date will be calculated as specified in each of
the Affected Securities. UBS AG will pay investors holding Affected
Securities as of 5:00 p.m., New York time, on June 6, 2013, the
applicable call settlement amount.
About ETRACS
For further information about ETRACS ETNs, go to http://www.etracs.com.
ETRACS, are exchange-traded notes (ETNs), an innovative class of
investment products offering access to markets and strategies that may
not be readily available to investors, and offer unique diversification
opportunities in a number of different sectors. ETNs offer:
-
Access to asset classes with historically low correlations to more
traditional asset classes
-
Convenience of an exchange-traded security
-
Transparent exposure to a published index
ETRACS ETNs are senior unsecured notes issued by UBS AG, are traded on
NYSE Arca, and can be bought and sold through a broker or financial
advisor. An investment in ETRACS ETNs is subject to a number of
risks, including the risk of loss of some or all of the investor’s
principal, and is subject to the creditworthiness of UBS AG. We urge you
to read the more detailed explanation of risks described under “Risk
Factors” in the prospectus supplement for the ETRACS ETN.
This material is issued by UBS AG or an affiliate thereof ("UBS").
Products and services mentioned in this publication may not be available
for residents of certain jurisdictions. Past performance is not
necessarily indicative of future results. Please consult the
restrictions relating to the product or service in question for further
information. Activities with respect to US securities are conducted
through UBS Securities LLC, a US broker/dealer. Member of SIPC (http://www.sipc.org/).
The contents of any website referred to in this communication are not
part of, or incorporated by reference in, this communication. UBS has
filed a registration statement (including a prospectus, as supplemented
by a prospectus supplement for the offerings of the ETRACS ETNs) with
the Securities and Exchange Commission (the “SEC”) for the offerings to
which this communication relates. Before you invest, you should read
these documents and any other documents that UBS has filed with the SEC
for more complete information about UBS and the offering to which this
communication relates. You may get these documents for free by visiting
EDGAR on the SEC website at www.sec.gov.
Alternatively, you can request the prospectus and the applicable
prospectus supplement by calling toll-free (+1-877-387-2275).
© UBS 2013. The key symbol, UBS and ETRACS are among the registered and
unregistered trademarks of UBS. “ISE Solid State Drive Index™”, ”ISE
Cloud Computing™ Total Return Index”, “ISE™®” and “International
Securities Exchange®” are trademarks of International Securities
Exchange, LLC and have been licensed for use for certain purposes by UBS
Securities LLC and its affiliates. The Dow Jones-UBS Commodity IndexesSM
are a joint product of DJI OPCO, LLC, a subsidiary of S&P Dow Jones
Indices LLC, and UBS Securities LLC, and have been licensed for use.
“Dow Jones®”, “DJ”, “UBS”, “Dow Jones-UBS Commodity Index 2-4-6 Forward
Blend Total ReturnSM”, “Dow Jones-UBS Commodity Index 2 Month
ForwardSM”, “Dow Jones-UBS Commodity Index 4 Month ForwardSM”,
“Dow Jones-UBS Commodity Index 6 Month ForwardSM”, “Dow
Jones-UBS Commodity IndexSM” and “DJ-UBS CI” are trademarks
or service marks of Dow Jones Trademark Holdings, LLC and UBS AG, as the
case may be. ”UBS Bloomberg Constant Maturity Commodity Index” and
“CMCI” are service marks of UBS and/or Bloomberg. Patent Pending. UBS
assumes sole responsibility for this material, which has not been
reviewed by Bloomberg. S&P is a registered trademark of Standard &
Poor’s Financial Services LLC. Other marks may be trademarks of their
respective owners. All rights reserved.
Notes to Editors
About UBS
Headquartered in Zurich and Basel, Switzerland, UBS is a client-focused
financial services firm that offers a combination of wealth management,
asset management and investment banking services on a global and
regional basis. By delivering a full range of advice, products and
services to its private, corporate and institutional clients, UBS aims
to generate sustainable earnings, create value for its shareholders, and
become the choice of clients worldwide.
UBS is present in all major financial centers worldwide. It has offices
in over 50 countries, with about 36% of its employees working in the
Americas, 35% in Switzerland, 17% in the rest of Europe and 12% in Asia
Pacific. UBS employs about 62,000 people around the world. Its shares
are listed on the SIX Swiss Exchange and the New York Stock Exchange
(NYSE).
More information at the site of the bank: www.ubs.com
www.ubs.com/media

Contacts:
UBS AG
Media Enquiries
Megan Stinson, 212-713-1302
or
New
York:
Judi Flynn-Echeverria, 917-902-9726
Source: UBS AG
© 2026 Canjex Publishing Ltd. All rights reserved.